Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer

Breast Cancer Research and Treatment

Volumn 141, Issue 1, 2013, Pages 155-163

  Killelea, Brigid K ^a,b   Long, Jessica B ^a,b   Chagpar, Anees B ^a,b   Ma, Xiaomei ^a,b   Soulos, Pamela R ^a,b   Ross, Joseph S ^a,b   Gross, Cary P ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Imaging; Magnetic resonance imaging; Preoperative care; Surgery

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGED; ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER REGISTRY; CANCER STAGING; COHORT ANALYSIS; ELDERLY CARE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL APPROACH; TREND STUDY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INSURANCE COVERAGE; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, SEGMENTAL; MEDICARE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PREOPERATIVE CARE; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84884290358     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2656-1     Document Type: Article

References (44)

1. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE (2008) Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 196(3):389-397
2. Schnall MD, Blume J, Bluemke DA, Deangelis GA, Debruhl N, Harms S, Heywang-Kobrunner SH, Hylton N, Kuhl CK, Pisano ED et al (2005) MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92(1):32-38
3. Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl C, Julian TB, Hylton N, Weatherall P, O'Loughlin M et al (2005) Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92(1):9-15; discussion 15-16
4. Young P, Kim B, Malin JL (2012) Preoperative breast MRI in early-stage breast cancer. Breast Cancer Res Treat 135(3):907-912
5. Weber JJ, Bellin LS, Milbourn DE, Verbanac KM, Wong JH (2012) Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate. Arch Surg 147(9):834-839
6. Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM, Schulman KA (2010) Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA 303(16):1625-1631
7. Houssami N, Hayes DF (2009) Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 59(5):290-302
8. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS (2011) Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res 170(1):77-83
9. Breslin TM, Banerjee M, Gust C, Birkmeyer NJ (2013) Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer 119(6):1251-1256
10. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K et al (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106(1):35-41
11. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML et al (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118(9):2285-2292
12. Morrow M, Freedman G (2006) A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin N Am 14(3):363-378 vi
13. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356(13):1295-1303
14. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, Brandt KR, Pruthi S, Chute CG, Olson JE et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27(25):4082-4088
15. Jeevan R, Cromwell D, Browne J, Caddy C, J Pereira, Sheppard C, van der Meulen J (2011) Complication rates associated with mastectomy and breast reconstruction procedures. In: The Royal College of Surgeons of England: Nov 30 2011-Dec 2 2011 (Abstract)
16. Fourth annual report of the National Mastectomy and Breast Reconstruction Audit. http://www.ic.nhs.uk/mbr
17. Tuttle T, Jarosek S, Durham S et al (2012) Use of preoperative MRI among older women with ductal carcinoma in situ (DCIS) and early invasive breast cancer: use of preoperative breast MRI. Data points #13 (prepared by the University of Minnesota DEcIDE Center, under Contract No. HHSA290201000131). Agency for Healthcare Research and Quality, Rockville. AHRQ Publication No. 12-EHC086-EF. August 2012
18. Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8-27
19. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233-1241
20. Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E, Okunieff P (1995) Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332(14):907-911
21. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K (1992) Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 11:15-18
22. Blichert-Toft M, Nielsen M, During M, Moller S, Rank F, Overgaard M, Mouridsen HT (2008) Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 47(4):672-681
23. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227-1232
24. Sarrazin D, Le MG, Arriagada R, Contesso G, Fontaine F, Spielmann M, Rochard F, Le Chevalier T, Lacour J (1989) Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14(3):177-184
25. Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA (2000) Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92(17):1422-1429
26. Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M (2001) Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst 93(6):447-455
27. Fisher CS, Martin-Dunlap T, Ruppel MB, Gao F, Atkins J, Margenthaler JA (2012) Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Ann Surg Oncol 19(10):3246-3250
28. Rosen PP, Groshen S, Kinne DW, Hellman S (1989) Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 106(5):904-910
29. Zendejas B, Moriarty JP, O'Byrne J, Degnim AC, Farley DR, Boughey JC (2011) Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. J Clin Oncol 29(22):2993-3000
30. King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29(16):2158-2164
31. Stucky CC, Gray RJ, Wasif N, Dueck AC, Pockaj BA (2010) Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol 17(Suppl 3):330-337
32. Lostumbo L, Carbine N, Wallace J, Ezzo J (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2004(4):CD002748
33. Osman F, Saleh F, Corrigan M, Jackson T, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of NSQIP data. Ann Surg Oncol 20:2
34. Gahm JWM, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer - prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19(6):462-469
35. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW et al (2004) Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101(9):1977-1986
36. Woerdeman LA, Hage JJ, Smeulders MJ, Rutgers EJ, van der Horst CM (2006) Skin-sparing mastectomy and immediate breast reconstruction by use of implants: an assessment of risk factors for complications and cancer control in 120 patients. Plast Reconstr Surg 118(2):321-330; discussion 331-322
37. Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165-175
38. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92(13):1081-1087
39. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, Hanby A, Brown J (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375(9714):563-571
40. Peters NH, van Esser S, van den Bosch MA, Storm RK, Plaisier PW, van Dalen T, Diepstraten SC, Weits T, Westenend PJ, Stapper G et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 47(6):879-886
41. Parker A, Schroen A, Brenin DR (2013) MRI utilization in newly diagnosed breast cancer: a survey of practicing surgeons. Ann Surg Oncol 20:2600-2606
42. Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B, Lesnikoski BA, Long JB, Gross CP (2012) Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol 30(35):4302-4307
43. Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X (2013) The cost of breast cancer screening in the Medicare population. JAMA Intern Med 173(3):220-226
44. Roberts KB, Soulos PR, Herrin J, Yu JB, Long JB, Dostaler E, Gross CP (2013) The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Int J Radiat Oncol Biol Phys 85(5):1186-1192